| Market Cap | 93.87B | P/E | 56.39 | EPS this Y | -0.40% | Ern Qtrly Grth | 4.20% |
| Income | 1.7B | Forward P/E | 44.92 | EPS next Y | 18.40% | 50D Avg Chg | -21.00% |
| Sales | 5.71B | PEG | 2.80 | EPS past 5Y | 20.66% | 200D Avg Chg | -18.00% |
| Dividend | N/A | Price/Book | 7.86 | EPS next 5Y | 19.11% | 52W High Chg | -29.00% |
| Recommedations | 2.10 | Quick Ratio | 7.90 | Shares Outstanding | 357.24M | 52W Low Chg | 16.00% |
| Insider Own | 0.97% | ROA | 9.21% | Shares Float | 355.85M | Beta | 1.10 |
| Inst Own | 86.51% | ROE | 15.92% | Shares Shorted/Prior | 3.04M/2.72M | Price | 262.77 |
| Gross Margin | 69.33% | Profit Margin | 29.85% | Avg. Volume | 1,766,920 | Target Price | 337.04 |
| Oper. Margin | 31.89% | Earnings Date | Apr 18 | Volume | 2,521,891 | Change | -0.64% |
Intuitive Surgical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States and internationally. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D HD vision systems, skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. It also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures; and provides SimNow, a cloud-enabled simulation platform, which allows surgeons to learn and practice their surgical skills; Iris, an augmented reality imaging product for use in kidney procedures; and Intuitive Cloud that enables proactive monitoring and software updates. In addition, the company offers EndoWrist Stapler, a wristed stapling instrument for resection, transection, and creation of anastomoses; EndoWrist One Vessel Sealers that are wristed single-use instruments for bipolar coagulation and mechanical transection of vessels up to 7mm in diameter and tissue bundles that fit in the jaws of the instrument; E-100 generator, an electrosurgical generator; SureForm 45 Curved-Tip stapler; and SynchroSeal for sealing and transection with a single pedal press. Additionally, the company sells various accessories comprising sterile drapes for ensuring sterile field during surgery; and vision products that include replacement 3D stereo endoscopes, camera heads, light guides, and other items that facilitate the use of the da Vinci Surgical System, as well as Ion endoluminal system for biopsies. Intuitive Surgical, Inc. was founded in 1995 and is headquartered in Sunnyvale, California.
| Redburn Partners | Neutral | Jan 25, 22 |
| Deutsche Bank | Hold | Jan 21, 22 |
| Piper Sandler | Neutral | Jan 21, 22 |
| Wells Fargo | Overweight | Jan 21, 22 |
| Morgan Stanley | Equal-Weight | Jan 21, 22 |
| Raymond James | Outperform | Jan 21, 22 |
| Citigroup | Buy | Jan 21, 22 |
| BTIG | Buy | Jan 10, 22 |
| Morgan Stanley | Equal-Weight | Jan 7, 22 |
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Curet Myriam | EVP & Chief Medical.. EVP & Chief Medical Officer | Jan 25 | Option | 124.5 | 6,000 | 747,000 | 3,285 | 01/26/22 |
| Curet Myriam | EVP & Chief Medical.. EVP & Chief Medical Officer | Jan 25 | Sell | 263.94 | 6,000 | 1,583,640 | 285 | 01/26/22 |
| DeSantis Robert | EVP & Chief Product.. EVP & Chief Product Officer | Jan 25 | Option | 211.41 | 1,410 | 298,088 | 1,362 | 01/26/22 |
| DeSantis Robert | EVP & Chief Product.. EVP & Chief Product Officer | Jan 25 | Sell | 261.64 | 1,410 | 368,912 | 1,092 | 01/26/22 |
| Johnson Amal M | Director Director | Nov 24 | Option | 64.36 | 7,500 | 482,700 | 18,169 | 11/26/21 |
| Johnson Amal M | Director Director | Nov 24 | Sell | 333.73 | 7,500 | 2,502,975 | 10,669 | 11/26/21 |
| DeSantis Robert | EVP & Chief Product.. EVP & Chief Product Officer | Aug 27 | Sell | 1048.12 | 397 | 416,104 | 364 | 08/27/21 |
| DeSantis Robert | EVP & Chief Product.. EVP & Chief Product Officer | Aug 27 | Option | 736.8 | 397 | 292,510 | 761 | 08/27/21 |
| MOHR MARSHALL | Executive VP & CFO Executive VP & CFO | Apr 27 | Sell | 865.69 | 21,963 | 19,013,149 | 8,412 | 04/27/21 |
| MOHR MARSHALL | Executive VP & CFO Executive VP & CFO | Apr 27 | Option | 162.74 | 30,375 | 4,943,228 | 21,000 | 04/27/21 |
| Myriam Curet | EVP & Chief Medical.. EVP & Chief Medical Officer | Mar 02 | Option | 0 | 752 | 846 | 03/02/21 | |
| Myriam Curet | EVP & Chief Medical.. EVP & Chief Medical Officer | Mar 02 | Sell | 760 | 379 | 288,040 | 94 | 03/02/21 |
| MOHR MARSHALL | Executive VP & CFO Executive VP & CFO | Feb 17 | Option | 43.11 | 3,791 | 163,430 | 11,090 | 02/17/21 |
| DeSantis Robert | Executive VP & GM IA.. Executive VP & GM IA&E | Feb 17 | Option | 0 | 3,166 | 6,088 | 02/17/21 | |
| DeSantis Robert | Executive VP & GM IA.. Executive VP & GM IA&E | Feb 17 | Sell | 782 | 2,958 | 2,313,156 | 2,539 | 02/17/21 |
| Myriam Curet | EVP & Chief Medical.. EVP & Chief Medical Officer | Feb 17 | Option | 0 | 2,582 | 1,786 | 02/17/21 | |
| Myriam Curet | EVP & Chief Medical.. EVP & Chief Medical Officer | Feb 17 | Sell | 662.76 | 4,423 | 2,931,387 | 94 | 02/17/21 |
| MOHR MARSHALL | Executive VP & CFO Executive VP & CFO | Oct 27 | Option | 127.91 | 6,000 | 767,460 | 20,673 | 10/27/20 |
| MOHR MARSHALL | Executive VP & CFO Executive VP & CFO | Oct 27 | Sell | 715.28 | 6,000 | 4,291,680 | 14,673 | 10/27/20 |